Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure-Reference-Cited by-同舟云学术

Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure

Published:2011-07-22 Issue:3 Volume:21 Page:233-240
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Desai Rishi J.¹,Ashton Carol M.²,Deswal Anita³⁴⁵,Morgan Robert O.⁶,Mehta Hemalkumar B.⁷,Chen Hua⁷,Aparasu Rajender R.⁷,Johnson Michael L.³⁷⁵

Affiliation:

1. Eshelman School of Pharmacy; University of North Carolina; Chapel Hill NC USA

2. Department of Surgery; Methodist Institute for Technology, Innovation and Education; Houston TX

3. Michael E. DeBakey VA Medical Center; Houston TX USA

4. Baylor College of Medicine; Houston TX USA

5. Houston Center for Quality of Care and Utilization Studies; Houston TX USA

6. School of Public Health; University of Texas Health Science Center at Houston; Houston TX USA

7. College of Pharmacy; University of Houston; Houston TX USA

Funder

Agency for Healthcare Research and Quality

Department of Veterans Affairs, Health Services Research and Development Service

Houston VA HSR&D Center of Excellence

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.2175/fullpdf

Reference25 articles.

1. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure;Go;Am J Cardiol,2007

2. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee;Lloyd-Jones;Circulation,2009

3. Do ACE inhibitors/Angiotensin II type 1 receptor antagonists reduce hospitalisations in older patients with heart failure? A propensity analysis;Trewet;Drugs Aging,2007

4. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE);Pitt;Lancet,1997

5. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II;Pitt;Lancet,2000

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating Adherence to Concomitant Diabetes, Hypertension, and Hyperlipidemia Treatments and Cardiovascular Outcomes Among Elderly Patients Using Marginal Structural Modeling;High Blood Pressure & Cardiovascular Prevention;2022-09-24

2. Evaluating adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments and intermediate outcomes among elderly patients using marginal structural modeling;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-06-09

3. Real world data and data science in medical research: present and future;Japanese Journal of Statistics and Data Science;2022-04-13

4. Pharmacoepidemiology in Cardiorenal Medicine;Textbook of Cardiorenal Medicine;2020-11-25

5. Pharmacological treatments of cardiovascular diseases: Evidence from real-life studies;Pharmacological Research;2017-04